Aehr Test Systems shares took a hit after Teradyne introduced its new Titan HP tester, but Oppenheimer analysts say the selloff may be based on a misunderstanding of what each company's equipment actually does. In a note, the investment bank argued that investors are treating Teradyne's Titan HP and Aehr's FOX platform as direct substitutes, when in fact they are aimed at different stages of the chip manufacturing and testing process.
Two different testing steps
Chip testing isn't a single step. It happens at multiple points along the way from raw silicon to a finished, packaged chip. The two stages at the center of this debate are wafer-level burn-in and system-level test.
Wafer-level burn-in, which is what Aehr's FOX platform does, involves stressing chips while they are still on the silicon wafer, before they are cut apart and packaged. This early stress test is designed to flush out weak or defective chips before the expensive steps of packaging and assembly. Catching failures this early can save manufacturers significant money by avoiding the cost of packaging a chip that will later fail.
System-level test, which Teradyne's Titan HP targets, checks a fully packaged chip or module. This is a later-stage test that verifies the final product works as intended in a system-like environment.
Oppenheimer's key point is that these are not interchangeable. A chip can go through both wafer-level burn-in and system-level test as part of the same manufacturing and qualification chain. The two tools are complementary, not competing, in many production flows.
Why it matters for AI chips
The distinction is especially important for high-power AI chips, which generate significant heat during operation. That concentrated heat can create "hotspots" on the chip and, in extreme cases, lead to thermal runaway, where rising temperatures cause more current to flow, generating even more heat until the chip fails.
Because of this reliability risk, manufacturers of AI accelerators have a strong incentive to screen out defective chips as early as possible. Wafer-level burn-in is often pulled forward when reliability risk is high, because catching failures earlier can cut scrap and rework later and speed qualification for volume production. In Oppenheimer's view, that makes Aehr's FOX platform more valuable in the AI era, not less.
The firm argues that the launch of Teradyne's Titan HP does not meaningfully increase competitive overlap with Aehr's FOX. Instead, the bigger driver of Aehr's story is whether FOX proves itself in real production flows, not whether a rival launched new hardware.
What to watch next
Oppenheimer reiterated an outperform rating and a $120 price target on Aehr, even as the stock traded at $73.51 after the Teradyne announcement. That implies significant upside if the firm's thesis plays out.
The analysts pointed to several near-term proof points that could validate the FOX platform's adoption:
- Pilot-production validation in Taiwan, which could signal that major foundries or OSATs (outsourced semiconductor assembly and test companies) are seriously evaluating the technology.
- Potential broader adoption by hyperscalers, the big cloud-computing firms that design and deploy their own AI chips at massive scale.
- Interest from a "second major AI processor" customer, which would diversify Aehr's customer base beyond its current primary AI chip customer.
If these milestones are met, Oppenheimer expects higher-value FOX configurations and follow-on demand to materialize. If they stall, the stock could remain under pressure despite the favorable competitive positioning.
What it means for investors
For everyday investors, the key takeaway is that not all chip testing is the same, and a competitor's product launch doesn't automatically spell doom for a smaller player. The market's initial reaction to Teradyne's Titan HP may have been an overreaction if the two products serve different niches.
However, it's also worth remembering that Aehr's stock is highly sensitive to news about its largest customers and the pace of AI chip adoption. The company's fortunes are tied to the broader AI infrastructure buildout, which has been a major driver of semiconductor demand. Investors should watch for updates on the Taiwan pilot, hyperscaler interest, and any announcements about new AI processor customers, as these are the concrete milestones that could move the stock.
As always, it's important to do your own research and consider how a stock fits into your overall portfolio. Analyst price targets are opinions, not guarantees, and the semiconductor testing market is competitive and fast-moving.
